Ticker
MRSNCompany Name
MERSANA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 84.57M | $ 20.62M | 24.38% |
3/31/2025 | $ 112.47M | $ 24.62M | 21.89% |
12/31/2024 | $ 144.66M | $ 28.6M | 19.77% |
9/30/2024 | $ 169.53M | $ 31.5M | 18.58% |
6/30/2024 | $ 179.13M | $ 32.31M | 18.04% |
3/31/2024 | $ 198.37M | $ 33.08M | 16.67% |
12/31/2023 | $ 226.06M | $ 33.63M | 14.88% |
9/30/2023 | $ 262.9M | $ 34.34M | 13.06% |
6/30/2023 | $ 311M | $ 35.03M | 11.26% |
3/31/2023 | $ 296.19M | $ 35.68M | 12.05% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for MERSANA THERAPEUTICS INC is calculated as follows: Debt [ $ 16.83M ] / Assets [ $ 290.13M ]
(=) Debt to Assets [ 5.8% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.49% |